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Background: PCI is increasingly acceptable in selected patients with 3VD &/or LMS
coronary disease. To establish the value of the Global Risk Categorisation (GRC), a
combination of the SYNTAX score (SXscore) & additive EuroSCORE, in determining
the optimal revascularisation modality within the randomised SYNTAX population
(n=1800).
Methods: Prior to randomisation, the SXscore & EuroSCOREs were collected in
CABG (n=890) & PCI (n=899) populations, consisting of pre-specified powered LMS
& 3VD cohorts. The primary (all-cause-death) & secondary (MACCE) endpoints at
36-months were analysed in pre-defined low (n=921), intermediate (n=687) & high
(n=181) risk categories.
Results: At 36-months within the randomised PCI population, the SXscore could not
identify a low-risk group. Conversely the GRC, within both the LMS & 3VD PCI
cohorts, was able separate a low risk group (GRClow) for death and MACCE, from
the GRCint-high groups. Within the CABG population, significant differences in death
and MACCE were evident between the GRCint-high groups only. Comparative
analyses between CABG and PCI for the GRClow LMS cohort, demonstrated a higher
mortality with CABG compared to PCI (CABG: 7.5%, PCI: 1.2%, HR 0.16 [95% C.I.
0.03, 0.70], p=0.0054), and a trend towards a reduced incidence of MACCE (CABG:
23.1%, PCI: 15.8%, HR 0.64 [95% C.I. 0.39, 1.07], p=0.088). Within the GRClow
3VD cohort, no statistically significant differences in death (CABG: 5.2%, PCI: 5.8%,
HR 1.14 [95% C.I. 0.57, 2.30], p=0.71) or MACCE (CABG: 19.0%, PCI: 24.7%, HR
1.35 [95% C.I. 0.95, 1.92], p=0.10) were evident. Risk-model performance measures
within the LMS PCI cohort established a clear incremental benefit of the GRC
compared to the EuroSCORE and SXscores individually. Within the 3VD PCI cohort,
the risk-model performance measures of the GRC were comparable to EuroSCORE –
the GRC however still proved to better risk stratify patients compared to the SXscore
and EuroSCORE alone. Reclassification analyses confirmed that the GRC
appropriately reclassified patients.
Global Risk Model-incorporating historically defined ranges of additive
EuroSCORE & SXscore
Conclusion: The identification of low GRC patients may further aid in the risk
stratification of patients within the randomised SYNTAX population.
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Background: Based on clinical observations by Optical Coherence Tomography
(OCT), we hypothesized that Kissing-Balloon (KB) post-dilatation in bifurcations,
despite its usefulness in optimizing the ostium of the Side Branch (SB), can produce
significant detrimental stent distortion in the proximal Main Vessel (MV) and
frequently fails to ensure complete apposition of the proximal section of the stent.
Methods: Commercially available stents (Xience V, Taxus Liberté and Presillion,
n=14) were deployed to a diameter of 3.0 mm in a silicone model of a coronary
bifurcation (MV=3.5 mm proximal tapering to 2.5 mm distal, MV/SB angle = 45°)
using a provisional stenting approach. After SB dilatation with a 2.5 Non Compliant
(NC) balloon and simulatenous KB inflation, we investigated the benefits of using a
NC balloon sized to post-dilate only the proximal segment of the stent in the MV,
thereby taking into consideration the natural diameter ratio between vessels in a
bifurcation according to Murray’s law.
Results: From 3D micro-CT quantification, the percentage of malapposed struts in the
proximal part of the vessel was reduced from 33.4 % with final KB to 0.6 % with the
proposed Final Proximal Inflation (FPI) (p=0.02). FPI ensured circular expansion of
the stent and the Minimum stent area proximal to the SB was also increased from 6.8
mm2 after KB to 8.5 mm2 after FPI (p < 0.0001).
Final Proximal Post-Dilatation after KB
Conclusion: Final proximal dilatation of stents with an appropriately sized balloon
achieves systematically, unlike final kissing balloon dilatation, complete stent
apposition in the main vessel and optimal stent geometry. Such final step may improve
outcome in bifurcation stenting.
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Background: Percutaneous treatment of unprotected distal left main (UDLM) remains
a challenging procedure for most interventional cardiologists associated to higher rate
of target lesion revascularization (TLR) and target vessel revascularization (TVR) -
particularly at the ostium circumflex artery- or major adverse cardiac events (MACE).
We performed a retrospective study to compare two different cross-over techniques in
ULDM : Left Main-Anterior Descending (LM-LAD) versus Left-Main-Circumflex
(LM-CX).
Methods: From January 2007 to December 2010, 144 patients with ULDM were
treated at our centre with provisional cross-over techniques ( single stent ) . We
compared patients undergone LM-CX with those undergone LM-LAD. The primary
end-point was the long-term rate of major adverse cardiac events (MACE, i.e. the
composite of death, myocardial infarction and repeat revascularization).
Results: A total of 144 patients, 42 (29 %) underwent LM-CX stenting and 102 (71%)
LM-LAD. Significant baseline differences were found for coronary dominance (75%
right dominance in the TC-CX group versus 94% in the other, p=0.004). Myocardial
infarction as indication to PCI was more frequent in group TC-CX (41% VS 24%
p=0.04).After a median follow up of 23 months, MACE rate was not statistical
significantly different between the two cohorts (23% versus 24% p=0.38),whereas
ULM TLR rate was significantly higher in the LM-LAD group (0% versus 9%
p=0.04).There were no other significant differences in the individual components of
the primary end point; however, there was a trend toward statistically significant higher
rate of death for all causes in patients with TC-CX (17% versus 10% p=0.17). Finally
there were no Stent thrombosis events in both groups.
Conclusion: Provisional distal Left main bifurcation single stent treatment results is
safe and effective therapeutic option, without differences in long-term outcome
relatively to stent cross-over left main to LAD or left main to circumflex.
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Background: Stent deployment across side branch (SB) ostium is common in daily
practice. The present study investigated the natural history of SBs jailed by drug eluting
stents (DES).
Methods: Of 642 patients with 756 lesions treated with DES between April 2007 and
March 2008,the Thrombolysis In Myocardial Infarction (TIMI) flow grades of 271
consecutive de-novo SBs (>1mm) jailed by DES in 196 patients were assessed
immediately after the procedure and at 9 months(follow-up angiogram rate:89.0%).
Patients receiving any SB intervention were excluded.
Results: Of 271 jailed SBs, occlusion occurred in 6.27% and deterioration of flow
occurred in 6.27% immediately after stenting. In patients with these SB changes, peri-
procedural myocardial infarction was more likely than in those without (10.0% vs.
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1.8%, p=0.017), while there was no increase of cardiac death or life-threatening
complications such as stent thrombosis and Q-wave myocardial infarction during
follow up. At 9 months, angiography showed that one third of the initially obstructed
SBs were still occluded. In contrast, flow was maintained in almost all (98.6%) SBs
with early TIMI flow grade 3 and there was no delayed occlusion of these branches.
In multiple regression analysis, Medina bifurcation class (1,1,1) (OR 24.7, 95%CI 3.3-
185.7; p<0.01), SB jailed by stent overlap zone (OR 5.74, 95%CI 1.0-32.8; p<0.05),
and calcified lesion (OR 4.6, 95%CI 1.1-19.7; p<0.01) were related to flow-detrioration
in jailed SB. Preprocedure TIMI grade2 flow in SB (OR 5.9, 95%CI 1.3-27.7; p<0.05)
was contributors of SB occlusion. .
Conclusion: Jailed SBs showing good flow after stenting had a favorable angiographic
and clinical outcome after 9 months of follow-up. However, pre-procedural lesion
complexity and technical factors should be considered to avoid SB occlusion/flow
deterioration associated with periprocedural myocardial infarction.
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Background: Low coronary artery wall shear stress (WSS) promotes atherogenesis.
Intravascular ultrasound (IVUS) studies of distal left main coronary artery (LMCA)
lesions have shown that 90% have plaque from the LMCA to the left anterior
descending (LAD), 65% have plaque from the LMCA into the left circumflex (LCX),
and that the carina is rarely diseased (Circ Cardiovasc Interv. 2010;3:105-12).
Methods: We used computational fluid dynamics (CFD) to assess WSS and plaque
distribution at the distal LMCA bifurcation in 12 pts. Coronary computed tomography
(CT) was the initial screening test followed by coronary angiography and Virtual
Histology Intravascular Ultrasound (VH-IVUS). Vascular numerical analysis assisted
by computer-aided design measured WSS in 3 regions; [1] LM into proximal LAD,
[2] LMCA into proximal LCX, and [3] flow divider (carina). VH-TCFA was defined
as necrotic core >10% of plaque area within a plaque burden of >40% and >30°
abutting the lumen in >3 consecutive frames.
Results: Seven pts were amenable for WSS analysis. As shown in the Figure, peak
WSS tended to be lower from LMCA into proximal LAD than from LMCA into
proximal LCX (p=0.201) and was lower from distal LMCA into either proximal LAD
or LCX than at the flow divider (p=0.033 and p=0.059, respectively). In 3 pts with
VH-LM-TCFA, WSS was low and similar in both the LAD and LCX (4.44±4.79 Pa in
LAD vs 4.52±3.88 Pa in LCX, p=0.9), but was higher in one side of the LMCA
bifurcation than the other (3 LCX and 1 LAD) in non-TCFA.
Conclusion: CFD calculation of WSS accurately predicts reported patterns of
atherosclerotic plaque distribution at the distal LMCA bifurcation and may be
associated with VH-TCFA distribution.
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Background: Percutaneous treatment of coronary bifurcation lesions continues to be
challenging and is associated with suboptimal results even with the use of drug-eluting
stents (DES). These lesions are present in up to 30 percent of all patients (P). Dedicated
bifurcation stents provide an attractive solution considering that two-stent technique
or provisional stenting approaches are not always the best solution.
Methods: In a prospective multi-center single-arm national study, we characterize the
procedural and 6-month clinical outcomes of the Tryton side branch stent, a novel
device for the treatment of bifurcation lesions.Between August 2009 and March 2011,
a total of 147consecutive P were treated with the Tryton at 10 Spanish Centers.
Procedural data was obtained on 137 P, of these 64 have reached 6 months. In this
series 63 percent of the lesions were located in the LAD and 85 percent of the cases
were true bifurcations . The Tryton is a thin strut, cobalt chromium, balloon expandable
stent which is employed in a culotte style. The Tryton is composed of three zones which
correspond to the side branch, the carina and main vessel. After lesion pre-treatment,
the Tryton is positioned and deployed with the transition zone straddling the side branch
origin. A regular DES is then tracked into main vessel.
Results: The primary endpoint was 6-month major adverse cardiac events (MACE:
cardiac death, myocardial infarction, target lesion revascularization). Secondary end
points were technical and procedural success. Technical and procedural success
occurred in 96.6% and 97.4% respectively. The MACE rate at 6-month follow-up was
4.8%,(1 cardiac death, 1.6% MI and 3.2% target lesion revacularization with stenosis
in the main vessel and side branch equally divided(1.6%). One case of stent
dislodgement was observed (0.7%).
Conclusion: Our series confirms the very good results of Tryton Side Branch Stent
when evaluated in a real world setting in conjunction with the investigators choice of
‘work horse’ DES.
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Background: There is a little available data regarding the long term follow-up of
patients treated with Sirolimus-eluting stents (SES) for unprotected left main (ULM)
disease.
Methods: All consecutive patients with ULM stenosis between March 2002 and
December 2008 were included in this retrospective analysis. The primary end-point of
the study was a composite of major adverse cardiovascular events (MACE) defined as
all cause death, myocardial infarction (MI) and target lesion revascularization (TLR)
according to lesion location and stenting strategy. Secondary endpoints were the
individual components of MACE.
Results: During the study period, 436 consecutive patients with ULM disease
underwent SES implantation. The median follow-up period was 1370 days (IQR 836-
2926 days). Sixty-six patients (15.1%) had a non-bifurcation lesion (NB-group) and
370 patients (84.9%) had distal bifurcation disease (DB-group). In the DB-group, a 1-
stent strategy (1-SS) was used in 227 patients (61.4%) and a 2-stent strategy (2-SS) in
143 patients (38.6%). MACE within 5 years occurred in 3 patients (4.5%) in the NB-
group and in 107 (28.9%) in the DB-group; 50 patients (22.0%) with a 1-SS and 55
(38.5%) with a 2-SS (p=0.001). Cardiac-death was observed in 1 patient (1.5%) in the
NB-group and in 24 patients (6.5%) in the DB-group; 15 patients (6.6%) with a 1-SS
and 9 patients (6.3%) with a 2-SS (p=1.0). MI was observed 3 patients (1.3%)
following a 1-SS and in 5 patients (3.5%) following a 2-SS, while no MI was observed
in the NB-group. In the DB group, the rate of TLR in the entire bifurcation (main
branch [MV] and side branch [SB]) within 5 years was 16.0% versus 36.0%, in the
MV alone was 9.4% versus 13.7%, and in the SB alone was 7.6% versus 22.3% in the
1-SS versus 2-SS respectively.
Conclusion: Although long-term outcomes in patients with non-distal bifurcation ULM
disease were favorable, outcomes in patients with distal ULM lesions treated with the
2-SS appeared worse than the 1-SS which reflected initial lesion severity and
complexity.
www.JACC.TCTAbstracts2011
B88 JACC Vol 58/20/Suppl B  |  November 7-11, 2011  |  TCT Abstracts/POSTER/Left Main and Bifurcation Stenting
P
O
S
T
E
R
S
